TP53 and lung carcinoma: Furthermore, tyrosine kinase inhibitors, such as sunitinib and cisplatin, were found to inhibit VEGF-A secretion from the A549 lung cancer cell line via p53-independent and p53-dependent mechanisms, respectively.